首页> 外国专利> CRYSTALLINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOLE-5-YL)-8,9-DIHYDRO-2H-PYRIDO4,3,2-DEPHTHALAZINE-3(7H)-ON TOSYLATE

CRYSTALLINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOLE-5-YL)-8,9-DIHYDRO-2H-PYRIDO4,3,2-DEPHTHALAZINE-3(7H)-ON TOSYLATE

机译:晶体(8S,9R)-5-FLUORO-8-(4-Fluorophhenyl)-9-(1-Methylyl-1H-1,2,4-triazole-5-YL)-8,9-DIHYDRO-2H-PYRIDO [4,3,2-DE]酞嗪-3(7H)-对甲苯磺酸盐

摘要

To provide a cancer treatment agent having inhibitory effect on enzymatic activity of poly(ADP-ribose)polymerase (PARP) protein family.SOLUTION: There is provided tosylate of crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazole-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazine-3(7H)-on. The salt exhibits an X ray powder diffraction pattern including peaks of 2θ angle±0.2 of 7.5, 20.1 and 24.1, the X ray powder diffraction pattern including peaks of 2θ angle±0.2 of 7.5, 15.1, 18.1, 20.1, 20.5, 22.6 and 24.1, and solidCNMR spectrum having peaks of 143.2, 136.0, 131.8, 123.9, 112.2, 105.2 and 100.3 ppm±0.2 ppm.SELECTED DRAWING: None
机译:为了提供一种对聚(ADP-核糖)聚合酶(PARP)蛋白家族的酶活性具有抑制作用的癌症治疗剂。解决方案:提供了结晶的(8S,9R)-5-氟-8-(4-氟苯基)甲苯磺酸酯)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氢-2H-吡啶并[4,3,2-去]酞嗪-3(7H)- 。该盐表现出的X射线粉末衍射图包括2θ角±0.2为7.5、20.1和24.1的峰,该X射线粉末衍射图包括2θ角±0.2为7.5、15.1、18.1、18.1、20.1、20.5、22.6和24.1的峰。 ,以及具有143.2、136.0、131.8、123.9、112.2、105.2和100.3 ppm±0.2 ppm的峰的solidCNMR光谱。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号